Domestic devices left their mark on the 12th Turkish Medical Congress, which was opened in Tersane Istanbul with the participation of Minister of Health Kemal Memişoğlu. Minister of Health Memişoğlu said, "We have delivered our respirators to 45 countries and provided relief to 8 million people, and we are delivering our automatic shock devices to 18 countries. We have introduced our local hepatitis and chickenpox vaccines. We continue our project work for eight different vaccines. We have started to use our heart-lung machine, which has three international awards, in surgeries. We have put our local mobile digital x-ray devices and intensive care monitors equipped with advanced features into service in our public hospitals."
Ministers of Health from many countries also made speeches and thanked Turkey for the organization. Nobel Prize Winner Prof. Dr. Aziz Sancar also took part in the opening of the congress. Speaking to Hürriyet, Turkish Health Institutes Presidency (TÜSEB) President Prof. Dr. Ümit Kervan also announced that the kits developed by TÜSEB will provide significant benefits in cancer treatment and diagnosis and will be put into use in a short time.
CANCER CAN BE TREATED BEFORE IT STARTS
TÜSEB Cancer Researcher Assoc. Dr. Demet Akdeniz Ödemiş said: "HerediTR is a kit that detects a person's cancer risk and guides them to take protective measures for the person. It is the first kit produced domestically. With the production of this kit, the technical infrastructure consists of 34 genes. It has the potential to predict risks for 15 different types of cancer. We have produced it at standards equal to international kits. It will be used integrated with the Ministry of Health as a kit with which we can detect people's cancer risk. It also has a package including software. This opens the way for our physicians, genetics It is a road map that makes the process easier in the process of creating a clinical report. Here, the person's cancer risk can be predicted and preventive measures can be taken. In addition, in vitro fertilization treatment can be performed to prevent the transfer of the gene mutation to the next generations. It can be used in 15 different types of cancer such as breast, lung, prostate, pancreas and colon. Another kit includes OncoTR. "We can detect this effectively and see how we should direct the person's treatment approach. There are similar products of this kit in the international arena, but we will present it to the Ministry of Health as the first kit we have produced locally."
Doc. Dr. Demet Akdeniz Ödemiş - Prof. Dr. Burak Civelek - Prof. Dr. Ebru Ozgur
'IT WILL BE AVAILABLE IN THE FIRST HALF OF 2027'
President of Turkish Cancer Institute Prof. Dr. Burak Civelek said, "With the OncoTR kit, we create a comprehensive map of the genetic structure of the cancer by looking at 690 different genetic regions. Thanks to this map, we determine which treatments the person can benefit from more. We organize the treatment accordingly. We see whether he can benefit from immunotherapies and smart drugs and whether he should use them. Thus, the doctor can create a personalized treatment plan for his patient. In this way, the tumor can be treated more precisely and with greater success with fewer side effects. The software for this was also made in Turkey and is much more sensitive and much more accurate." "It was produced cheaply. We will make it available to humanity. We have two different genomic profiling, including 691 and 104 genes, that will be available to our people, especially city hospitals, in the first half of 2027."
TÜSEB Cancer Researcher Prof. Dr. Ebru Özgür said that as a result of her studies, patients can be followed with a blood test instead of a biopsy. He stated that in this way, tests involving radiation such as PET will be performed less frequently on the patient.
